Outcome of interest
| | |
No. of
|
No. of
|
Effects
|
SMD
|
95% CI
|
Heterogeneity
|
P-value
|
---|
| | |
study
|
patients
|
model
| | |
P value
|
I
2 (%)
| |
| | |
arms
| | | | | | | |
TC
| | |
6
|
436
|
Random
|
−0.375
|
−0.757 to 0.006
|
0.002
|
73.80
|
0.054
|
|
Form of intervention
|
Turmeric powder
|
2
|
186
|
Fixed
|
−0.000
|
−0.288 to 0.288
|
0.272
|
17.10
|
0.999
|
| |
Turmeric extract
|
2
|
103
|
Fixed
|
−0.584
|
−0.980 to −0.188
|
0.228
|
31.10
|
0.004*
|
|
Type of disease
|
MetS
|
2
|
136
|
Fixed
|
−0.934
|
−1.289 to −0.579
|
0.510
|
0.000
|
<0.0001***
|
| |
Hyperglycemia
|
4
|
300
|
Fixed
|
−0.059
|
−0.285 to 0.168
|
0.561
|
0.000
|
0.612
|
-
MetS metabolic syndrome
- *p < 0.05
- **p < 0.001
- ***p < 0.0001